Skip to main content
DH

Drug Hunter

The startup has developed a collaborative drug discovery platform that enables researchers to share insights, data, and achievements in real-time. This platform addresses the challenge of fragmented communication among drug hunters, fostering a community that enhances knowledge exchange and accelerates the discovery process.

Happy Valley, United StatesFounded 202110150K+ followers
Updated 3 months ago

Funding

$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Drug discovery is often hampered by fragmented communication and data silos among researchers, hindering efficient knowledge exchange and slowing down the overall process. Scientists need a centralized platform to share insights, data, and achievements in real-time to accelerate the identification of promising drug candidates.

Solution

Drug Hunter is a collaborative online platform designed to streamline drug discovery by fostering real-time knowledge sharing and collaboration among researchers. The platform provides a centralized hub for scientists to access and exchange insights, data, and achievements related to drug discovery. By connecting researchers and providing access to a comprehensive database of drug-related information, Drug Hunter accelerates the identification of potential drug candidates and promotes innovation in the field. The platform offers tools for structure searching, patent analysis, and target identification, enabling researchers to make informed decisions and advance their projects more efficiently.

Target Audience

The primary target audience includes medicinal chemists, drug discovery researchers, and pharmaceutical professionals working in both industry and academia.

Features

  • Structure search functionality for identifying compounds with desired characteristics.
  • Patent search tool for analyzing intellectual property related to drug candidates.
  • Curated database of approved drugs with detailed information on their properties and mechanisms of action.
  • Resources section providing access to relevant articles, presentations, and other materials.
  • Alerts system for staying up-to-date on the latest developments in the field.
  • Molecule highlights showcasing promising drug candidates and their development progress.
  • Articles covering key topics in drug discovery, including M&A activity, clinical trial updates, and patent trends.
This profile is AI-generated and may contain inaccuracies.